Agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders
申请人:PÉCSI TUDOMÁNYEGYETEM
公开号:US10344032B2
公开(公告)日:2019-07-09
The present invention relates to 4-phenetylamino-7H-pyrrolo[2,3-d]pyrimidine derivatives of the and solvates, hydrates and pharmaceutically acceptable salts thereof, processes for manufacturing of them, the use of them, as well as pharmaceutical compositions containing at least one of them as pharmaceutically active agent(s) together with pharmaceutically acceptable carrier, excipient and/or diluents, especially for the prevention and/or treatment of acute neurogenic inflammation and/or neuropathic hyperalgesia. Said 4-phenetylamino-7H-pyrrolo[2,3-d]pyrimidine compounds have been identified as new drug candidates for the prevention and/or treatment of acute neurogenic inflammation and/or neuropathic hyperalgesia.
本发明涉及4-苯乙酰胺基-7H-吡咯并[2,3-d]嘧啶衍生物及其溶解物、水合物和药学上可接受的盐、它们的制造工艺、它们的用途,以及含有至少一种它们作为药学活性剂的药物组合物和药学上可接受的载体、赋形剂和/或稀释剂,特别是用于预防和/或治疗急性神经源性炎症和/或神经病理性痛觉减退。所述 4-苯乙胺基-7H-吡咯并[2,3-d]嘧啶化合物已被确定为预防和/或治疗急性神经源性炎症和/或神经病理性痛觉减退的候选新药。